Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Chlormadinone Acetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 7/20 | 1.00 |
| ▸ | AR | P10275 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 3/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 6/20 | 0.80 |
| ▸ | MEN1 | O00255 | 4/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlormadinone Acetate SCHEMBL29430402 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL11795531 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL15046 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL1460594 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL4948575 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL1460593 | 1.00 | AR (1.00) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL23908022 | 0.99 | AR (0.98) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL1250000 | 0.90 | AR (0.82) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| Chlormadinone Acetate SCHEMBL9572032 | 0.90 | CYP3A4 (0.80) | ARCYP3A4NR3C1PGRSMN1; SMN2 | |
| SCHEMBL11512932 | 0.89 | AR (0.81) | ARCYP3A4NR3C1PGRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6625 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053736-A1 | LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION | BAYER OY (FI) | 2026-02-26 | — | — | US | claimed |
| EP-4463570-B1 | METHOD FOR HORMONE OR DRUG SCREENING IN A TISSUE SAMPLE | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2026-01-14 | — | — | EP | claimed |
| EP-4643858-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UTERINE DISEASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-11-05 | — | — | EP | claimed |
| EP-4638443-A1 | TRANSIENT RECEPTOR POTENTIAL VANILLOID 6 INHIBITORS | Uniquest Pty Limited (AU) | 2025-10-29 | — | — | EP | claimed |
| EP-4608405-A1 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Veradermics, Incorporated (US) | 2025-09-03 | — | — | EP | claimed |
| US-20250262192-A1 | PROGNOSTIC PATHWAYS FOR HIGH RISK SEPSIS PATIENTS | KONINKLIJKE PHILIPS N.V. (NL) | 2025-08-21 | — | — | US | claimed |
| US-20250215039-A1 | NUCLEOSIDES FOR TREATING CANCER | PRIMEFOUR THERAPEUTICS INC (US) | 2025-07-03 | — | — | US | claimed |
| US-20250154601-A1 | METHOD FOR HORMONE OR DRUG SCREENING IN A TISSUE SAMPLE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2025-05-15 | — | — | US | claimed |
| EP-4463570-A1 | METHOD FOR HORMONE OR DRUG SCREENING IN A TISSUE SAMPLE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2024-11-20 | — | — | EP | claimed |
| US-20240293329-A1 | PHARMACEUTICALLY STABLE SOFT CAPSULE COMPRISING TWO OR MORE DIFFERENT COMPOSITIONS | COSMAXPHARMA CO.,LTD. (KR) | 2024-09-05 | — | — | US | claimed |
| US-4885289-A | APPLYING ANTIANDROGEN TO SKIN | GILLETTE COMPANY | 1989-12-05 | — | — | US | claimed |
| US-4801460-A | N-VINYLPYRROLIDONE POLYMER BINDER | BASF AKTIENGESELLSCHAFT (DE) | 1989-01-31 | — | — | US | claimed |
| US-4720489-A | Hair growth modification with ornithine decarboxylase inhibitors | GILLETTE COMPANY, THE, A DELAWARE CORPORATION | 1988-01-19 | — | — | US | claimed |
| EP-0165970-A4 | HAIR GROWTH MODIFICATION. | KASZYNSKI EDWIN G (US) | 1987-09-15 | — | — | EP | claimed |
| US-4598072-A | Combinations of an aromatase-inhibitor and an antiandrogen for prophylaxis and/or treatment of benign prostatic hyperplasia | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | claimed |
| EP-0165970-A1 | HAIR GROWTH MODIFICATION. | KASZYNSKI EDWIN G (US) | 1986-01-02 | — | — | EP | claimed |
| WO-1985002543-A1 | HAIR GROWTH MODIFICATION | KASZYNSKI EDWIN G (US) | 1985-06-20 | — | — | WO | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4171358-A | ADMINISTERING PROGESTATIONAL AGENTS | ELI LILLY AND COMPANY (US) | 1979-10-16 | — | — | US | claimed |
| US-4018919-A | IN MAMMALS | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | claimed |